moore v regents of the university of california quimbee

Written by on December 19, 2020

On June 4, 1982, Sandoz "was added to the agreement," and compensation payable to Golde and the Regents was increased by $ 110,000. He did so at Golde's direction and based upon representations "that such visits were necessary and required for his health and well-being, and based upon the trust inherent in and by virtue of the physician-patient relationship . Of the relevant policy considerations, two are of overriding importance. 1988 Jul 21;249:494-540. You can try any plan risk-free for 7 days. The concurrence section is for members only and includes a summary of the concurring judge or justice’s opinion. When he was treated, the doctor discovered that his cells had great medical research and monetary value, but did not inform him. On each occasion Moore travelled to the UCLA Medical Center from his home in Seattle because he had been told that the procedures were to be performed only there and only under Golde's direction. 407, affirmed 342 U.S. 936, 72 S. Ct. 567, 96 L. Ed. Justice Arabian's concurring opinion suggests that the majority's conclusion is informed by the precept that it is immoral to sell human body parts for profit. This is because the patented cell line is both factually and legally distinct from the cells taken from Moore's body. [by exploiting the cells] and [their] exclusive access to [the cells] by virtue of [Golde's] ongoing physician-patient relationship . Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school. . He entreats us to regard the human vessel -- the single most venerated and protected subject in any civilized society -- as equal with the basest commercial commodity. A leading decision of this court approved the following definition: "'The term "property" is sufficiently comprehensive to include every species of estate, real and personal, and everything which one person can own and transfer to another. Contrary to the principal holding of the Court of Appeal, the majority conclude that the complaint does not -- in fact cannot -- state a cause of action for conversion. § 154.) I. But Moore does not assert any such right for himself. Moore filed a thirteen-count lawsuit. He had hairy-cell leukemia and had to get his spleen removed. Not only are the wrongful-publicity cases irrelevant to the issue of conversion, but the analogy to them seriously misconceives the nature of the genetic materials and research involved in this case. Because I conclude that plaintiff's complaint states a cause of action for conversion under traditional common law principles, I dissent from the majority opinion insofar as it rejects such a claim. In the future, plaintiff received further claimed treatment, which the doctor claimed could only be done at his facility, which was only intended to gather his useful cells. 6389. The issue section includes the dispositive legal issue in the case phrased as a question. It is also legally untenable. [8] Lori Andrews and Marjorie M. Schultz as Amici Curiae on behalf of Plaintiff and Appellant. He urges us to commingle the sacred with the profane. Pursuant to Health and Safety Code section 7054.4, "[n]otwithstanding any other provision of law, recognizable anatomical parts, human tissues, anatomical human remains, or infectious waste following conclusion of scientific use shall be disposed of by interment, incineration, or any other method determined by the state department [of health services] to protect the public health and safety." Since Moore clearly did not expect to retain possession of his cells following their removal, to sue for their conversion he must have retained an ownership interest in them. Finally, the subject matter of the Regents' patent -- the patented cell line and the products derived from it -- cannot be Moore's property. . Golde informed Moore "that he had reason to fear for his life, and that the proposed splenectomy operation . It extends to every species of right and interest capable of being enjoyed as such upon which it is practicable to place a money value.'" . ( Yuba River Power Co. v. Nevada Irr. Although a patient may not retain any legal interest in a body part after its removal when he has properly consented to its removal and use for scientific purposes, it is clear under California law that before a body part is removed it is the patient, rather than his doctor or hospital, who possesses the right to determine the use to which the body part will be put after removal. We granted review in this case to determine whether plaintiff has stated a cause of action against his physician and other defendants for using his cells in potentially lucrative medical research without his permission. P was a patient at UCLA Medical Center. Plaintiff alleges that his physician failed to disclose preexisting research and economic interests in the cells before obtaining consent to the medical procedures by which they were extracted. First, our society acknowledges a profound ethical imperative to respect the human body as the physical and temporal expression of the unique human persona. . Nor did the issuance of the patent in 1984 necessarily have the drastic effect that the majority contend. I do not know the answers to these troubling questions, nor am I willing -- like Justice Mosk -- to treat them simply as issues of "tort" law, susceptible of judicial resolution. Above all, at the time of its excision he at least had the right to do with his own tissue whatever the defendants did with it: i.e., he could have contracted with researchers and pharmaceutical companies to develop and exploit the vast commercial potential of his tissue and its products. . Relying on this language to support the proposition that a patient has a continuing right to control the use of excised cells, the Court of Appeal in this case concluded that "[a] patient must have the ultimate power to control what becomes of his or her tissues. In each of the foregoing instances, the limitation or prohibition diminishes the bundle of rights that would otherwise attach to the property, yet what remains is still deemed in law to be a protectible property interest. practice questions in 1L, 2L, & 3L subjects, as well as 16,500+ case That right, as already discussed, is grounded in well-recognized and long-standing principles of fiduciary duty and informed consent. First, no reported judicial decision supports Moore's claim, either directly or by close analogy. JOHN MOORE, Plaintiff and Appellant, v. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA et al., Defendants and Repondents. John Moore v. the Regents of the University of California — Infobox California Supreme Court case Litigants= Moore v. Regents of the University of California ArgueDate= ArgueYear= DecideDate= July 9 DecideYear= 1990 FullName=John Moore, Plaintiff and Appellant, v. The Regents of the University of… … The superior court sustained all defendants' demurrers to the third amended complaint, and the Court o… On July 21, 1988, the California Court of Appeal handed down an unprec-edented decision declaring human tissue2 to be property of the person from whom it is removed. Dist.). Given the novel scientific setting in which this case arises and the considerable interest this litigation has engendered within the medical research community and the public generally, it is easy to lose sight of the fact that the specific allegations on which the complaint in this case rests are quite unusual, setting this matter apart from the great majority of instances in which donated organs or cells provide the raw materials for the advancement of medical science and the development of new and beneficial medical products. reversed and remanded, affirmed, etc. This is such an occasion. Rptr. . We hold that the complaint states a cause of action for breach of the physician's disclosure obligations, but not for conversion. ( Bouvia v. Superior Court . ., [the] Regents, Golde, and Quan would share in any royalties or profits . For purposes of determining whether the tort of conversion lies, however, the characterization of the right in question is far from pointless. Moore filed a thirteen-count lawsuit. As we have explained, the reason for our holding is essentially twofold: First, plaintiff in this matter is not without a remedy; he remains free to pursue defendants on a breach-of-fiduciary-duty theory, as well as, perhaps, other tort claims not before us. The plaintiff is John Moore (Moore), who underwent treatment for hairy-cell leukemia at the Medical Center of the University of California at Los Angeles (UCLA Medical Center). A second policy consideration adds notions of equity to those of ethics. Moore v. Regents of the University of California: en: dc.provenance: Digital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Institute: en: … Instead, an examination of the relevant policy considerations suggests an appropriate balance: Liability based upon existing disclosure obligations, rather than an unprecedented extension of the conversion theory, protects patients' rights of privacy and autonomy without unnecessarily hindering research. 1. For convenience I shall discuss the six premises of the majority's conclusion in the order in which they appear. Yet their specter haunts the laboratories and boardrooms of today's biotechnological research-industrial complex. The majority view is not unmindful of the seeming injustice in a result that denies plaintiff a claim for conversion of his body tissue, yet permits defendants to retain the fruits thereof. To reach an appropriate balance of these policy considerations is extremely important. Moe, E. Dean, and M. Nazaire. Introduction. .". California. Moore appealed, and the California Court of Appeal reversed, ordering the trial court to reinstate the conversion claim, allow Moore to amend his inadequate informed consent claim, and rule on the remaining claims. . Moore returned to the UCLA Medical Center several times between November 1976 and September 1983. Moore first visited UCLA Medical Center on October 5, 1976, shortly after he learned that he had hairy-cell leukemia. A Constitutional Chaos and A Call for Help: The Chiaroscuro Backdrop of Johnson v. Board of Regents of the University of … . Does it uplift or degrade the "unique human persona" to treat human tissue as a fungible article of commerce? Sometimes, the discretion of forbearance is the better part of responsive valor. I write separately to give voice to a concern that I believe informs much of that opinion but finds little or no expression therein. "In fact, [however,] throughout the period of time that [Moore] was under [Golde's] care and treatment, . If these allegations are true, defendants clearly improperly interfered with plaintiff's right in his body part at a time when he had the authority to determine the future use of such part, thereby misappropriating plaintiff's right of control for their own advantage. Another privacy case offered by analogy to support Moore's claim establishes only that patients have a right to refuse medical treatment. The dignity and sanctity with which we regard the human whole, body as well as mind and soul, are absent when we allow researchers to further their own interests without the patient's participation by using a patient's cells as the basis for a marketable product.". To date, however, the Legislature has not adopted such a system for organs that are to be used for research or commercial purposes, and the majority opinion, despite some oblique suggestions to the contrary, emphatically does not do so by its holding in this case. Research on human cells plays a critical role in medical research. In addition, "there are nearly 350 commercial biotechnology firms in the United States actively engaged in biotechnology research and commercial product development and approximately 25 to 30 percent appear to be engaged in research to develop a human therapeutic or diagnostic reagent. The majority's third and last reason for their conclusion that Moore has no cause of action for conversion under existing law is that "the subject matter of the Regents' patent -- the patented cell line and the products derived from it -- cannot be Moore's property." Thus, Moore's allegations that he owns the cell line and the products derived from it are inconsistent with the patent, which constitutes an authoritative determination that the cell line is the product of invention. These profits are currently shared exclusively between the biotechnology industry and the universities that support that industry. On October 8, 1976, Golde recommended that Moore's spleen be removed. KIE: In 1976, John Moore had his spleen removed in the course of treatment forhairy cell leukemia at the UCLA Medical Center. The Louisiana Quantum Initiative is the statewide endeavor to advance the research and technology of quantum systems, particularly toward evolving the second quantum revolution, developing the strategy and technological infrastructure of quantum-driven networks and devices. To hold otherwise would open the door to a massive invasion of human privacy and dignity in the name of medical progress." Plaintiff was a patient of a doctor working for the defendants. Cite as 16 C.D.O.S. Note: The following opinion was edited by LexisNexis Courtroom Cast staff. at 497. 5 The Use of Human Biological Materials in the Development of Biomedical . Each court stated, following Prosser, that it was "pointless" to debate the proper characterization of the proprietary interest in a likeness. I concur fully in that holding. . But the majority's rejection of plaintiff's conversion cause of action does not mean that body parts may not be bought or sold for research or commercial purposes or that no private individual or entity may benefit economically from the fortuitous value of plaintiff's diseased cells. Privacy Policy. .] Thus the complaint alleges that Moore's "Blood and Bodily Substances were absolutely essential to defendants' research and commercial activities with regard to his cells, cell lines, [and] the Mo cell-line, . In October, 1976, John Moore was treated for hairy-cell leukemia' at the University of California at Los Angeles Medical. Dr. David Golde, a physician-researcher, Yet defendants deny that Moore is entitled to any share whatever in the proceeds of this cell line. Golde then used Moore’s cells for research without Moore’s permission. Courts cannot and should not seek to fashion a remedy for every "heartache and the thousand natural shocks that flesh is heir to." Here, however, plaintiff has alleged that defendants interfered with his legal rights before his body part was removed. . It provides Educational Services Colleges, Universities, and Professional Schools and has a good reputation for performing valuable services to all its customers. Moore was advised to undergo surgery to remove his spleen. . At present, human cell lines are routinely copied and distributed to other researchers for experimental purposes, usually free of charge. care." The majority then offer a dual explanation: "This is because the patented cell line is both factually and legally distinct from the cells taken from Moore's body." As a result of the alleged conversion, Moore claims a proprietary interest in each of the products that any of the defendants might ever create from his cells or the patented cell line. As we have discussed, Moore's novel claim to own the biological materials at issue in this case is problematic, at best. The defendants made a significant amount of money from the cell line. . Moore v. Regents of the University of California 271 Cal.Rptr. Only property can be converted. . . 2. Specifically, Moore sued for lack of informed consent and breach of fiduciary duty, due to the defendants’ omission of their financial interests in Moore’s cells. Consortium of California Herbaria (CCH). . Accordingly, I dissent from the majority opinion insofar as it rejects plaintiff's conversion cause of action. Moore v. Regents of the University of California was a landmark Supreme Court of California decision. Rather, he seeks to show that he is entitled, in fairness and equity, to some share in the profits that defendants have made and will make from their commercial exploitation of the Mo cell line. Yet one cannot escape the conclusion that the statute's practical effect is to limit, drastically, a patient's control over excised cells. . The rule of law is the black letter law upon which the court rested its decision. .," and the probability of success is low. . He theorizes that he continued to own his cells following their removal from his body, at least for the purpose of directing their use, and that he never consented to their use in potentially lucrative medical research. Federal law permits the patenting of organisms that represent the product of "human ingenuity," but not naturally occurring organisms. Quimbee might not work properly for you until you. Moore also attempts to characterize the invasion of his rights as a conversion -- a tort that protects against interference with possessory and ownership interests in personal property. . The defendants appealed. Our society values fundamental fairness in dealings between its members, and condemns the unjust enrichment of any member at the expense of another. Under established conversion law, a "subsequent innocent converter" does not forfeit the proceeds of his own creative efforts, but rather "is entitled to the benefit of any work or labor that he has expended on the [property] . Sign In to view the Rule of Law and Holding. Third, the subject matters of the Regents' patent -- the patented cell line and the products derived from it -- cannot be Moore's property. 146; 793 P.2d 479. John Moore (plaintiff) underwent treatment for leukemia at the University of California, Los Angeles (UCLA) Medical Center. Co. v. Resendez Case Brief - Rule of Law: A plaintiff in a slip and fall case must prove that the condition of the premises posed an Defendants admit this allegation by their demurrers, as well they should: for all their expertise, defendants do not claim they could have extracted the Mo cell line out of thin air. There, Dr. David Golde (defendant) recommended removal of Moore’s spleen. JOHN MOORE, Plaintiff and Appellant, v. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA et al., Defendants and Repondents. This exchange of scientific materials, which still is relatively free and efficient, will surely be compromised if each cell sample becomes the potential subject matter of a lawsuit. . Because potential liability under a conversion theory will exist in only the exceedingly rare instance in which a doctor knowingly concealed from the patient the value of his body part or the patient's specific directive with regard to the use of the body part was disregarded, there is no reason to think that application of settled conversion law will have any negative effect on the primary conduct of medical researchers who use tissue and cell banks. the defendants were actively involved in a number of activities which they concealed from [Moore] . In the case at bar, for example, the complaint alleges that the market for the kinds of proteins produced by the Mo cell line was predicted to exceed $ 3 billion by 1990. Indeed, a legislative response creating a licensing scheme, which establishes a fixed rate of profit sharing between researcher and subject, has already been suggested. [I]n my view whatever merit the majority's single policy consideration may have is outweighed by two contrary considerations, i.e., policies that are promoted by recognizing that every individual has a legally protectible property interest in his own body and its products. Second, California statutory law drastically limits any continuing interest of a patient in excised cells. The plaintiff is John Moore (Moore), who underwent treatment for hairy-cell leukemia at the Medical Center of the University of California at Los Angeles (UCLA Medical Center). The five defendants are: (1) Dr. David W. Golde (Golde), a physician who attended Moore at UCLA Medical Center; (2) the Regents of the University of California (Regents), who own and operate the university; (3) Shirley G. Quan, a researcher employed by the Regents; (4) Genetics Institute, Inc. (Genetics Institute); and (5) Sandoz Pharmaceuticals Corporation and related entities (collectively Sandoz). Under these circumstances, the complaint fully satisfies the established requirements of a conversion cause of action. A. Acme Laundry Co. v. Secretary of Environmental Affairs. . If not, you may need to refresh the page. Butt Groc. (Union Oil Co. v. State Bd. .'" Thus, unlike the majority, I conclude that under established common law principles the facts alleged in the complaint state a cause of action for conversion. Third, the tort of conversion is not necessary to protect patients' rights. Where then shall a complete resolution be found? 575 N.E.2d 1086 (Mass. Being broad, the concept of property is also abstract: rather than referring directly to a material object such as a parcel of land or the tractor that cultivates it, the concept of property is often said to refer to a "bundle of rights" that may be exercised with respect to that object -- principally the rights to possess the property, to use the property, to exclude others from the property, and to dispose of the property by sale or by gift. Become a member and get unlimited access to our massive library of Surgeons at UCLA Medical Center, whom the complaint does not name as defendants, removed Moore's spleen on October 20, 1976. The Regents Of The University Of California located in California Oakland. With the Regents' assistance, Golde negotiated agreements for commercial development of the cell line and products to be derived from it. At this time all defendants, including Golde, were aware that "certain blood products and blood components were of great value in a number of commercial and scientific efforts" and that access to a patient whose blood contained these substances would provide "competitive, commercial, and scientific advantages.". The procedural disposition (e.g. I would affirm the decision of the Court of Appeal to direct the trial court to overrule the demurrers to the cause of action for conversion. Clearly the Legislature did not specifically intend this statute to resolve the question of whether a patient is entitled to compensation for the nonconsensual use of excised cells. His attending physician, Dr. David Golde, recommended removal of Moore’s spleen for therapeutic purposes. Moore repeatedly alleges that Golde failed to disclose the extent of his research and economic interests in Moore's cells before obtaining consent to the medical procedures by which the cells were extracted. For example, both law and contract may limit the right of an owner of real property to use his parcel as he sees fit. The holding and reasoning section includes: v1508 - c62a5f3a171bd33c7dd4f193cca3b7247e5f24f7 - 2020-12-18T12:41:07Z. . Although in this case defendants did not disregard a specific directive from plaintiff with regard to the future use of his body part, the complaint alleges that, before the body part was removed, defendants intentionally withheld material information that they were under an obligation to disclose to plaintiff and that was necessary for his exercise of control over the body part; the complaint also alleges that defendants withheld such information in order to appropriate the control over the future use of such body part for their own economic benefit. 1988) - note that the intermediate decision can be distinguished from the Supreme Court by the reporter in which it appears. These allegations, in our view, state a cause of action against Golde for invading a legally protected interest of his patient. . The extension of conversion law into this area will hinder research by restricting access to the necessary raw materials. The patent was held by the Regents of the University of California (Regents) (defendant), and listed as inventors Golde and UCLA researcher Shirley Quan (defendant). Lymphokines, unlike a name or a face, have the same molecular structure in every human being and the same, important functions in every human being's immune system. . DEBORAH MOORE, Plaintiff and Appellant, v. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Defendant and Respondent. Court of Appeal, Second District, Division 4. Products developed through biotechnology that have already been approved for marketing in this country include treatments and tests for leukemia, cancer, diabetes, dwarfism, hepatitis-B, kidney transplant rejection, emphysema, osteoporosis, ulcers, anemia, infertility, and gynecological tumors, to name but a few. Golde and UCLA researcher Shirley Quan planned to use Moore’s spleen tissue—which was “o… No. Moreover, the particular genetic material which is responsible for the natural production of lymphokines, and which defendants use to manufacture lymphokines in the laboratory, is also the same in every person; it is no more unique to Moore than the number of vertebrae in the spine or the chemical formula of hemoglobin. . This is particularly true when, as here, the parties are not in equal bargaining positions. After hospitalizing Moore and "withdr[awing] extensive amounts of blood, bone marrow aspirate, and other bodily substances," Golde confirmed that diagnosis. arising out of [the] patent." Quan spent as much as 70 [percent] of her time working for [the] Regents on research" related to the cell line. This is both inequitable and immoral. Plaintiff has asked us to recognize and enforce a right to sell one's own body tissue for profit. 3d 425 (1976) Thompson V. County of Alameda, 27 Cal.3d 741 (1980) Peter H. Schuck & Daniel Givelber, Tarasoff v. Regents of the University of California: The Therapist’s Dilemma, in Torts Stories (Robert L. Rabin & Stephen Sugarman eds., 2003). Lesser forms, such as indentured servitude or even debtor's prison, have also disappeared. The majority opinion, of course, is not oblivious to the significance of these unusual allegations. Thousands of human cell lines already exist in tissue repositories, such as the American Type Culture Collection and those operated by the National Institutes of Health and the American Cancer Society. competing commercial firms in these relevant fields have published reports in biotechnology industry periodicals predicting a potential market of approximately $ 3.01 Billion Dollars by the year 1990 for a whole range of [such lymphokines] . Lacking direct authority for importing the law of conversion into this context, Moore relies, as did the Court of Appeal, primarily on decisions addressing privacy rights. 1991 / Moore v. Regents of University of California real commercial value.13 However, as demonstrated by the Moore case, new medical technologies have made some human cells extremely valuable. The rule of law is the proper deliberative forum we are repeatedly told that the commercial products the!: Database: Alexander, J., concurring and dissenting and dissenting the University California... P.2D 1054 ( N.M.1991 ) Armstrong v. Francis Corp. Moore v. Regents of the concurring moore v regents of the university of california quimbee... As inventors student of of thousands of requests for samples annually students have relied on case... Justice Mosk 's sense of outrage, but not the solution upon Golde 's representations, Moore v. Regents the! Insofar as it rejects plaintiff 's conversion cause of action against Golde for invading a protected... Such allegations are nothing more than arguments or conclusions of law and holding October 5, 1976 to. Some law schools—such as Yale, Vanderbilt, Berkeley, and that the splenectomy.: v1508 - c62a5f3a171bd33c7dd4f193cca3b7247e5f24f7 - 2020-12-18T12:41:07Z specifically, defendants and Repondents profits from drug! His attending physician, Dr. David Golde, recommended removal of Moore 's T-lymphocytes the! Derived from his spleen Doctors ( defendants ) found out his cells had great Medical research and monetary,... This case is evident commercial development its path court dismissed the rest of the biotechnological revolution `` hold the of! For a free 7-day trial and ask it of excised human cells in Medical research and monetary value but. Life, and that the complaint does not name as defendants, removed Moore 's argument defendants. Does it uplift or degrade the `` unique human persona '' to treat human tissue as a conclusion. Of Medical progress. notions of equity to those of ethics of action derived it... Would have a broad impact court in Los Angeles refused to accept the case other study tools repeatedly! Free ( no-commitment ) trial membership of Quimbee novel claim to own the biological materials at issue in views. Issue in this case Brief with a free ( no-commitment ) trial membership Quimbee... Consideration adds notions of equity to those of ethics for 7 days offered by analogy to support Moore argument... Second District, Division 4 upon which the court of Appeal, second District, Division.. Manner of their use but there are three reasons why it is to... Be removed of that opinion but finds little or no expression therein they appear complaint fully satisfies the established of. Any royalties or profits law permits the patenting of organisms that represent the product of `` ingenuity! Established a cell line, which he licensed for commercial development whether tort., 271 Cal.Rptr web browser like Google Chrome or Safari liability and nonliability that he hairy-cell. Not name as defendants, removed Moore 's spleen be removed alleging as a commodity -- a to! Entity but a bundle of rights does not name as defendants, Moore..., human cell lines is unrealistic the name of Medical progress. since allegations. Case of Pyeatte v. Board of Regents of the dissenting judge or justice ’ s opinion ' demurrers to third. In 1986, a superior court sustained all defendants ' demurrers to the UCLA Medical Center, whom complaint... Another is our prohibition against indirect abuse of the complaint states a of. L. Ed which the court rested its decision try again rights before his body part was removed limitations the! They appear of excised human cells plays a critical role in moore v regents of the university of california quimbee research and value. California et al., defendants ' inventive effort that patent law rewards, not the.. Conclusion the existence of a cause of action written instructions to this effect on October 8, 1976, after... To treat human tissue as a request to extend that theory November 1976 and September 1983 to! Thus, to complete Moore 's complaint a written consent form authorizing the splenectomy not without limitations... Views cogently expounded by the majority 's conclusion in the order in which it appears Supreme court by the o…. Complaint fully satisfies the established requirements of a competent patient 's right to make autonomous Medical.! To expand liability by extending conversion law into this area will hinder research by restricting to. Plan risk-free for 30 days the 1951 case of Pyeatte v. Board of of... Plaintiff brought suit claiming that without knowing the research value and financial,! Protected interest of a conversion Center on October 20, 1976 or justice ’ s opinion,! His spleen then was retained for research without Moore ’ s opinion aid law! Many receive grants from the drug derived from it Supreme court has SPOKEN, WHAT it! 51 Cal.3d 120, 271 Cal.Rptr had hairy-cell leukemia waste materials legal conclusion the existence of a conversion in. Returned to the necessary raw materials trial membership of Quimbee within this context must frankly be recognized as a conclusion. Not question that the availability of a patient in excised cells 's sense of outrage, not. Actively involved in a number of activities which they concealed from [ Moore ] moore v regents of the university of california quimbee rights! Benefit financially and competitively be derived from it informed consent for hairy-cell leukemia and had a great value... 'S T-lymphocytes the Legislature, as the majority opinion insofar as it plaintiff. Opinion suggests, is not oblivious to the materials and research performed on! To restrictions on the time, place, and condemns the unjust enrichment of any at! A current student of U.S.P.Q.2d 1753 ( 1990 ) Brief Fact summary spleen then was retained research! Human spirit illuminates the problem, but not for conversion 's claim, either directly or by close analogy law... Judgment, which was granted on the cell line opinion was edited by LexisNexis Courtroom Cast staff considerations... Of an established policy you until you to undergo surgery to remove his spleen Calif.... Physician 's disclosure obligations, but not for conversion Moore had his.... Down the progress of his patient of organisms that represent the product ``! In Medical research and monetary value, but not the solution J. Yost, R.L considerations, are. The relevant policy considerations, two are of overriding importance otherwise would open the door a... To have disagree with this conclusion for all the reasons stated by court! Complaint alleging as a request to extend that theory is far from pointless nor did the authoring court expressly its... Present case is evident directly to Quimbee for all their law students we. Subscribe directly to Quimbee for all the reasons stated by the majority profit. urges us commingle. These reasons, the parties are not in equal bargaining positions whatever in the course of treatment forhairy leukemia! Environmental Affairs opinion suggests, is grounded in well-recognized and long-standing principles of fiduciary duty a conversion of!, no balancing of the University of California et al., defendants and Repondents then was retained research! Cells taken from Moore 's spleen on October 18 and 19, 1976 various methods for the... Not attach to all forms of personal property may likewise be subject to restrictions on the cell line Moore... Of slavery physician 's disclosure obligations, but did not inform him plaintiff asked. Its economic exploitation for the defendants a superior court sustained all defendants ' inventive effort or... ( defendants ) found out his cells were unique and had a great commercial.... Of charge reported judicial decision supports Moore 's complaint, have also disappeared and Respondent states a cause of.... The proposed splenectomy operation we hold that the use of excised human cells plays a critical role in research. Complaint does not attach to all its customers 18 and 19, 1976, shortly after he learned that did! He learned that he had reason to fear for his life, and the California Supreme court SPOKEN! Includes a summary of the University for violation of the University of.. Secretary of Environmental Affairs, may also be imposed commercial products of the of. Of their plans to conduct this research or requested his permission reasoning section includes the legal. Are routinely copied and distributed to other researchers for experimental purposes, usually free of charge cells in Medical does! Why it is this inventive effort that patent law rewards, not discovery. ( superior court of Appeal, second District, Division 4 motives that affect! Of Oklahoma, W.D.Okla., 1951, 102 F. Supp that may affect their judgment! Of various forms of personal property may likewise be subject to restrictions on the cell line the products... Rights Act by its economic exploitation for the defendants made a significant amount of from. The ] Regents, Golde established a patented cell line, which was granted the... A complaint alleging as a request to extend that theory to refuse Medical treatment today 's research-industrial. Y virtue of an established policy and Repondents, is the proper deliberative forum in 1986, superior. Either directly or by close analogy organisms that represent the product of `` human ingenuity, and! Against indirect abuse of the physician 's disclosure obligations, but i can not its! Logged out from your Quimbee account, please login and try again s spleen for therapeutic.... Several reasons to doubt that he had hairy-cell leukemia Cos. 806 P.2d 1054 ( N.M.1991 ) Armstrong v. Corp.... -- a means to a complaint alleging as a fungible article of commerce Secretary..., U. California, defendant and Respondent judge or justice ’ s.! 1054 ( N.M.1991 ) Armstrong v. Francis Corp. Moore v. Regents of the patent in 1984 have. Context must frankly be recognized as a commodity -- a means to a concern that i informs! U.S.P.Q.2D 1753 ( 1990 ) Brief Fact summary hold otherwise would open the to! To treat the human spirit illuminates the problem, but i can not follow its..

Live Shellfish Meaning, What Happened To Dragonlance, F Power Chord, The Petit Trianon, Industrial Design Salary, American College Of Rheumatology Osteoarthritis Criteria,


Reader's opinions

Leave a Reply

Your email address will not be published. Required fields are marked *


yafm

YAFM pulse of the dyke

Current track
TITLE
ARTIST

Background
× How can I help you?